Chronic Disease Management

The chronic disease management market encompasses consumers with chronic, complex conditions such as chronic kidney disease, diabetes, and heart disease. The challenges faced in this market are often compounded by the need for social services and supports. For provider organizations and health systems managing consumers with chronic conditions, a significant challenge that remains is addressing the rising cost of care for this population. As a result, payers are focusing on reducing the spend by increasing integrated models of care coordination across medical, behavioural, pharmacy, and social support systems. These new market forces are creating strategic opportunities for provider organizations that are serving this population.

Latest Resources

• The American Diabetes Association’s Innovation Fund Invests In UpDoc To Accelerate The Future Of AI-Driven Chronic Disease Management & Prevention
• Levrx Adds A New Feature To Manage Specialty Medications Across Pharmacies, Programs & Vendors
• Parkinson’s Disease Death Rate Among Older Adults Reached 72 Per 100,000 In 2024
• Alcohol-Related Hospitalizations Among Individuals With Cancer Increased 50% Between 2016 & 2021
• FlyteHealth Selected For CMS Health Tech Ecosystem Diabetes & Obesity Category
• Parkinson Disease Mortality Among Adults Age 65 & Older: United States, 2024
• Interim Final Rule: Medicaid Program; Community Engagement Requirement For Certain Individuals
• Digital Pathways To Consumer Support: A Conversation With Erine Gray, Founder & CEO Of Findhelp
• 2.60 Children Per 1,000 Ages 10 To 17 Have Type 2 Diabetes, More Than Triple The Rate In 2017
• Medicaid Expansion Associated With Reductions In Mortality Among Young Adults With Kidney Failure
• Osara Health Expands Cancer Coach Program Into Survivorship Care
• Twin Health Introduces Precision GLP-1 Stewardship Model, Helping Members Lose More Weight Without Long-Term Dependence
• Bariatric Surgery Cuts Five-Year Risk Of Kidney Failure, Heart Attack, & Death Among Adults With Chronic Kidney Disease
• Forward Motion On CCBHCs
• FlyteHealth & State Of Connecticut Evaluation Demonstrates Significant Medical Cost Savings & Nearly $30 Million In Pharmacy Cost Avoidance

See All

17% Of Japanese Adults With Chronic Pain Screen Positive For ADHD

Among Japanese adults with chronic pain, 17.1% screened positive for attention-deficit/hyperactivity disorder (ADHD), according to a recent study. The estimated ADHD prevalence among the general population of Japanese adults is 1.65%, compared to 17.1% among those with persistent chronic pain. The highest rate of ADHD-positive screenings, 27.4%, was among those who reported average pain levels of 9 or 10 on a 10-point pain severity scale. The data came from 958 adults who were first-time visitors… Read

• Two-Year Costs For GLP-1 Weight Loss Drugs Higher Than Bariatric Surgery
• Bariatric Surgery Volume Down 23% Between 2020 & 2024
• Alesis LLC Announces Joint Venture With First Sleep Center For Alesis OSA1 Treatment Of The Root Cause Of Most Sleep Apnea
• Alzheimer’s Association Launches (Re)think Your Brain To Drive Early Action On Brain Health
• Mercy Receives PCORI Funding To Expand Hypertension Care Program

To sign-up for monthly Chronic Disease Management alerts, you must be signed in to your account.